Durso Jerome Benedict — SEC insider filings

SEC reporting owner CIK 1698665. 22 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2020-08-25 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Altimmune, Inc. (ALT)President and CEO, Director85 legs · 93,200 sh · $263,403—4
INTERCEPT PHARMACEUTICALS, INC. (ICPT)CEO, Director14——30

Insider filings — Durso Jerome Benedict

FiledFormIssuerReported transactionsSource
2026-11-134Altimmune, Inc. (ALT)Purchase (P): 30,700 @ $1.62EDGAR
2026-08-134Altimmune, Inc. (ALT)Purchase (P): 15,000 @ $2.95EDGAR
2026-04-014Altimmune, Inc. (ALT)Purchase (P): 15,000 @ $3.14EDGAR
2026-03-094Altimmune, Inc. (ALT)Purchase (P): 20,000 @ $3.54EDGAR
2025-12-224Altimmune, Inc. (ALT)Purchase (P): 12,500 @ $4.13EDGAR
2025-12-014Altimmune, Inc. (ALT)Grant/award (A): 1,824,400 (derivative) @ $0 · Grant/award (A): 633,700 (derivative) @ $0EDGAR
2025-09-294Altimmune, Inc. (ALT)Grant/award (A): 48,800 (derivative) @ $0EDGAR
2025-02-254Altimmune, Inc. (ALT)Grant/award (A): 69,800 (derivative) @ $0EDGAR
2023-11-134INTERCEPT PHARMACEUTICALS, INC. (ICPT)Code (U): 51,815 @ $19 · Disposition to issuer (D): 102,825 @ $19 · Disposition to issuer (D): 60,900 (derivative) · Disposition to issuer (D): 82,700 (derivative) · Disposition to issuer (D): 3,419 (derivative) · Disposition to issuer (D): 16,581 (derivative) · +6 moreEDGAR
2023-01-314INTERCEPT PHARMACEUTICALS, INC. (ICPT)Grant/award (A): 50,400 @ $0 · Grant/award (A): 82,700 (derivative) @ $0EDGAR
2023-01-034INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 7,083 @ $12.37EDGAR
2022-01-314INTERCEPT PHARMACEUTICALS, INC. (ICPT)Grant/award (A): 35,700 @ $0 · Grant/award (A): 60,900 (derivative) @ $0EDGAR
2022-01-044INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 5,607 @ $16.29 · Tax withholding (F): 334 @ $16.29EDGAR
2021-10-054INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 289 @ $15.22EDGAR
2021-07-024INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 289 @ $20.47EDGAR
2021-04-054INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 289 @ $24.28EDGAR
2021-02-254INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 319 @ $28.12EDGAR
2021-01-264INTERCEPT PHARMACEUTICALS, INC. (ICPT)Grant/award (A): 46,000 @ $0 · Grant/award (A): 72,000 (derivative) @ $0EDGAR
2021-01-054INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 1,700 @ $24.70 · Tax withholding (F): 334 @ $24.70EDGAR
2020-11-254INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 319 @ $35.47EDGAR
2020-10-054INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 289 @ $42.08EDGAR
2020-08-254INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 319 @ $48.21EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1698665 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs